Education
About Us
Working with TipRanks
Follow Us
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
Allogeneic Nk Cells
Myositis, Scleroderma, Systemic Sclerosis (Ssc), Refractory Rheumatoid Arthritis (Ra), Idiopathic Inflammatory Myopathies (Iims), Rheumatoid Arthritis (Ra, Iim, Sjogren Syndrome, Sjogrens Disease
Phase II
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
May 19, 2025
―
Cyclophosphamide, Fludarabine, Gcc2005
Lymphoma, T-Cell
Phase I
Recruiting
Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
Nov 19, 2024
―
Rituximab, Cyclophosphamide, Fludarabine, Obinutuzumab, Ab-101
Lupus Nephritis - Who Class Iii, Lupus Nephritis - Who Class Iv, Sle, Refractory Systemic Lupus Erythematosus
Phase I
Recruiting
AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
Feb 09, 2024
―
Afm13, Cyclophosphamide, Fludarabine, Interleukin-2, Ab-101
Peripheral T Cell Lymphoma, Relapsed Or Refractory Hodgkin Lymphoma
Phase II
Terminated
Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL
May 19, 2023
―
Cyclophosphamide, Fludarabine, Ab-201
Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase I/II
Withdrawn
A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors
Dec 23, 2022
―
Rituximab, Bendamustine, Cyclophosphamide, Fludarabine, Interleukin-2, Ab-101
Non Hodgkin Lymphoma
Phase I/II
Active Not Recruiting
AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Dec 04, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Artiva Biotherapeutics, Inc. (ARTV) have in its pipeline
ARTV is currently developing the following drugs: Allogeneic Nk Cells, Cyclophosphamide, Fludarabine, Gcc2005, Rituximab, Cyclophosphamide, Fludarabine, Obinutuzumab, Ab-101. These drug candidates are in various stages of clinical development as the company works toward FDA approval.